ResearcherGraz University of TechnologyActive in the last 2 years

Heinz Wilfried Amenitsch

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0002-0788-1336; OpenAlex author ID A5028583687. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. Last author DOI 10.1039/d4nr02435d ↗
Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. Co-author DOI 10.3390/cancers13205155 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vincenzo La Vaccara · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Erica Quagliarini · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Luca Digiacomo · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Damiano D. Caputo · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Giulio Caracciolo · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Daniela Pozzi · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Roberto Coppola · 2 shared papers, 2021–2025 · strength 0.36
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗
Roberto Cammarata · 1 shared paper, 2025 · strength 0.23
- Paper Nanoparticle-protein corona enhances accuracy of Ca-19.9-based pancreatic cancer classification. DOI 10.1039/d4nr02435d ↗
Alessandro Coppola · 1 shared paper, 2021 · strength 0.13
- Paper Detection of Pancreatic Ductal Adenocarcinoma by Ex Vivo Magnetic Levitation of Plasma Protein-Coated Nanoparticles. DOI 10.3390/cancers13205155 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.